Fredun Pharmaceuticals Limited (BSE: 539730)
Health Care · Pharmaceuticals · IN
Rs1,435.15
-7.28% today · +239.9% 1Y
Fredun Pharmaceuticals Limited (BSE: 539730) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $248.06M.
Over the last twelve months the share price has gained 239.9%, trading between 362.00 and 1.60K.
Tweenvest scores Fredun Pharmaceuticals Limited across four factors: quality 65/100, value 35/100, growth 100/100, dividend 22/100. Its strongest factor is growth.
539730 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $248.06M
- Revenue (TTM)
- $78.67M
- P/E
- 61.13
- EPS
- 23.48
- Dividend yield
- 0.02%
- Beta (5Y)
- 0.69
- 52-week high
- Rs1,600.00
- 52-week low
- Rs362.00
- Avg volume (3M)
- —
- Shares outstanding
- 16.54M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,245.00 | -0.15% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $271.54 | -0.55% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $151.00 | +0.23% |
| Roche Holding AGSWX: ROP | $368.80B | CHF370.90 | +0.13% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.72 | +0.51% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.04 | +0.25% |
Figures last refreshed Aug 18, 2026.